Furthermore, survival analysis suggested the level of Loricrin (LOR) was statistically significantly associated with the disease-free survival of HNSCC patients, indicating the potential of utilizing it as prognosis predictor. The gene discussed is LORICRIN; the disease is head and neck squamous cell carcinoma.